Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mindi J TenNapel

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
American Journal of Clinical Oncology|August 2, 2019
The Impact of Radiotherapy Facility Volume on the Survival and Guideline Concordance of Patients With Muscle-invasive Bladder Cancer Receiving Bladder-preservation TherapyKevin A D'Rummo, Mindi J TenNapel, Xinglei Shen
Practical Radiation Oncology|October 22, 2019
Assessing the Financial Toxicity of Radiation Oncology Patients Using the Validated Comprehensive Score for Financial Toxicity as a Patient-Reported OutcomeKevin A D'Rummo, Leah Miller, Mindi J TenNapel, et al.
Frontiers in Oncology|September 29, 2017
CASTLE Thyroid Tumor: A Case Report and Literature ReviewChris Lominska, Christopher Fleighton Estes, Prakash C Neupane, et al.
International Journal of Radiation Oncology, Biology, Physics|May 8, 2014
Risk of radiation-induced malignancy with heterotopic ossification prophylaxis: a case-control analysisArshin Sheybani, Mindi J TenNapel, William D Lack, et al.
Plos One|December 27, 2014
SIRT6 minor allele genotype is associated with >5-year decrease in lifespan in an aged cohortMindi J TenNapel, Charles F Lynch, Trudy L Burns, et al.
Head & Neck|March 12, 2019
Weekly cisplatin chemotherapy dosing versus triweekly chemotherapy with concurrent radiation for head and neck squamous cell carcinomaRyan T Morse, Rohit G Ganju, Mindi J TenNapel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2019
First-in-Human Phase I Clinical Trial of Pharmacologic Ascorbate Combined with Radiation and Temozolomide for Newly Diagnosed GlioblastomaBryan G Allen, Kellie L Bodeker, Mark C Smith, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
American Journal of Clinical Oncology|August 2, 2019
The Impact of Radiotherapy Facility Volume on the Survival and Guideline Concordance of Patients With Muscle-invasive Bladder Cancer Receiving Bladder-preservation TherapyKevin A D'Rummo, Mindi J TenNapel, Xinglei Shen
Practical Radiation Oncology|October 22, 2019
Assessing the Financial Toxicity of Radiation Oncology Patients Using the Validated Comprehensive Score for Financial Toxicity as a Patient-Reported OutcomeKevin A D'Rummo, Leah Miller, Mindi J TenNapel, et al.
Frontiers in Oncology|September 29, 2017
CASTLE Thyroid Tumor: A Case Report and Literature ReviewChris Lominska, Christopher Fleighton Estes, Prakash C Neupane, et al.
International Journal of Radiation Oncology, Biology, Physics|May 8, 2014
Risk of radiation-induced malignancy with heterotopic ossification prophylaxis: a case-control analysisArshin Sheybani, Mindi J TenNapel, William D Lack, et al.
Plos One|December 27, 2014
SIRT6 minor allele genotype is associated with >5-year decrease in lifespan in an aged cohortMindi J TenNapel, Charles F Lynch, Trudy L Burns, et al.
Head & Neck|March 12, 2019
Weekly cisplatin chemotherapy dosing versus triweekly chemotherapy with concurrent radiation for head and neck squamous cell carcinomaRyan T Morse, Rohit G Ganju, Mindi J TenNapel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2019
First-in-Human Phase I Clinical Trial of Pharmacologic Ascorbate Combined with Radiation and Temozolomide for Newly Diagnosed GlioblastomaBryan G Allen, Kellie L Bodeker, Mark C Smith, et al.
Pageof 1